Found 4 matching trials
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
PHASE1The study is being conducted to explore the reasonable dosage and evaluate ...
Location
Hunan Provincial Cancer Hospital
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
PHASE1This study is a phase Ib/II study to evaluate the efficacy, safety and tole...
Location
Sun Yat-Sen University Cancer Center
A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC
PHASE2The study is being conducted to to explore the reasonable dosage and evalua...
Location
Shanghai Pulmonary Hospital
A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy
PHASE2The study is being conducted to explore the reasonable dosage and evaluate ...
Location
Shandong Cancer Hospital